Proposed Pharmacological Treatments for COVID-19: Previously Confirmed Drugs
Background: The outbreak of severe acute respiratory syndrome coronavirus-2, also called 'coronavirus disease 2019' (COVID-19), first appeared in December 2019 in Wuhan, China. COVID-19 is caused by an enveloped single-stranded RNA virus, which has affected more than 14 million people arou...
Saved in:
Main Authors: | Fatemeh Bahoosh Feyzabadi (Author), Alireza Nikjoo (Author), Mohammad Reza Lagzian (Author), Hessamedin Babaei (Author), Melika Nasehi (Author) |
---|---|
Format: | Book |
Published: |
Mazandaran University of Medical Sciences,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Learn-confirm in model‐informed drug development: Assessing an immunogenicity quantitative systems pharmacology platform
by: Linnea C. Franssen, et al.
Published: (2023) -
Erjingwan and Alzheimer's disease: research based on network pharmacology and experimental confirmation
by: Yuya Xu, et al.
Published: (2024) -
A review on Quarantine during COVID-19 Outbreak: Lessons Learned from Previous Epidemics
by: Kimia Vakili, et al.
Published: (2020) -
Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 in South of Iran
by: Alireza Mirahmadizadeh, et al.
Published: (2023) -
Genome-Wide Mapping of Consanguineous Families Confirms Previously Implicated Gene Loci and Suggests New Loci in Specific Language Impairment (SLI)
by: Adnan Yousaf, et al.
Published: (2024)